These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 7974360
1. Platelet thrombospondin interactions with human high and low molecular weight kininogens. DeLa Cadena RA, Wyshock EG, Kunapuli SP, Schultze RL, Miller M, Walz DA, Colman RW. Thromb Haemost; 1994 Jul; 72(1):125-31. PubMed ID: 7974360 [Abstract] [Full Text] [Related]
2. Expression of thrombospondin 1 on the surface of activated platelets mediates their interaction with the heavy chains of human kininogens through Lys 244-Pro 254. DeLa Cadena RA, Kunapuli SP, Walz DA, Colman RW. Thromb Haemost; 1998 Jan; 79(1):186-94. PubMed ID: 9459346 [Abstract] [Full Text] [Related]
3. Insights on monoclonal antibodies to kininogens' heavy chain which influence kininogens' binding to platelets. Jiang Y, Nawarawong W, Meloni FJ, Schmaier AH. Thromb Haemost; 1992 Aug 03; 68(2):143-8. PubMed ID: 1412158 [Abstract] [Full Text] [Related]
4. High molecular weight kininogen binds to platelets by its heavy and light chains and when bound has altered susceptibility to kallikrein cleavage. Meloni FJ, Gustafson EJ, Schmaier AH. Blood; 1992 Mar 01; 79(5):1233-44. PubMed ID: 1536948 [Abstract] [Full Text] [Related]
5. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor. Yabkowitz R, Dixit VM. Cancer Res; 1991 Jul 15; 51(14):3648-56. PubMed ID: 1712244 [Abstract] [Full Text] [Related]
6. The 140-kilodalton antiangiogenic fragment of thrombospondin-1 binds to basic fibroblast growth factor. Taraboletti G, Belotti D, Borsotti P, Vergani V, Rusnati M, Presta M, Giavazzi R. Cell Growth Differ; 1997 Apr 15; 8(4):471-9. PubMed ID: 9101093 [Abstract] [Full Text] [Related]
7. Cytokeratin 1 and gC1qR mediate high molecular weight kininogen binding to endothelial cells. Joseph K, Ghebrehiwet B, Kaplan AP. Clin Immunol; 1999 Sep 15; 92(3):246-55. PubMed ID: 10479529 [Abstract] [Full Text] [Related]
9. Residues F16-G33 and A784-N823 within platelet thrombospondin-1 play a major role in binding human neutrophils: evaluation by two novel binding assays. Majluf-Cruz A, Manns JM, Uknis AB, Yang X, Colman RW, Harris RB, Frazier W, Lawler J, DeLa Cadena RA. J Lab Clin Med; 2000 Oct 15; 136(4):292-302. PubMed ID: 11039850 [Abstract] [Full Text] [Related]
10. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1. Merle B, Malaval L, Lawler J, Delmas P, Clezardin P. J Cell Biochem; 1997 Oct 01; 67(1):75-83. PubMed ID: 9328841 [Abstract] [Full Text] [Related]
11. Binding of thrombospondin to human plasma lipoproteins. Muraishi A, Capuzzi DM, Tuszynski GP. Biochem Biophys Res Commun; 1993 Jun 30; 193(3):1145-51. PubMed ID: 8323538 [Abstract] [Full Text] [Related]
12. The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface. DeLa Cadena RA, Colman RW. Protein Sci; 1992 Jan 30; 1(1):151-60. PubMed ID: 1304876 [Abstract] [Full Text] [Related]
13. Commercial immunodepleted deficient plasmas contain cleaved high molecular weight kininogen (HK). Mannhalter C, Lang H. Thromb Haemost; 1988 Dec 22; 60(3):447-52. PubMed ID: 3238647 [Abstract] [Full Text] [Related]